{"id":371717,"title":"Notice to stakeholders – Implementation of ICH M13A: Bioequivalence for immediate release solid oral dosage forms - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T15:11:05.581000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-ich-m13a-bioequivalence-immediate-release-solid-oral-dosage-forms.html","snippet":"Notice to stakeholders – Implementation of ICH M13A: Bioequivalence for immediate release solid oral dosage forms December 27, 2025 Our file number: 25-102237-854 Background The International Council for Harmonisation (ICH)'s guideline entitled, ICH M13A: Bioequivalence for…","rawSnapshotUrl":"/api/snapshots/raw/371717","browseUrl":"https://replay.healtharchive.ca/job-6/20260411151105/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-ich-m13a-bioequivalence-immediate-release-solid-oral-dosage-forms.html#ha_snapshot=371717","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}